|Articles|December 22, 2016

Moffitt Cancer Center Chooses Cryoport for Logistics

Moffitt Cancer Center has chosen cryogenic logistics company, Cryoport to provide support for its immunology program, cancer research, therapy programs and lab moves.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© Crystal light - © Crystal light - stock.adobe.com.

Moffitt Cancer Center Chooses Cryoport for Logistics

Newsletter

Related Content

Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials

ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness

Driving Collaboration Across Functions to Streamline Drug Development

Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer

Adaptive Trial Design as a Pathway to Faster Development

Trending on Applied Clinical Trials Online

Driving Collaboration Across Functions to Streamline Drug Development

Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials

ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness